Richard Fair
Board Member
Enliven Therapeutics, Inc. (ELVN)Equibles does not estimate personal net worth.
Get an email with a short summary when Enliven Therapeutics, Inc. publishes a filing, an earnings call transcript or a press release.
Get ELVN alertsAbout Richard Fair
Richard Fair is recorded as Board Member and CEO at Enliven Therapeutics, Inc. (ELVN). The newest filing on record that lists Richard Fair as Board Member and CEO at Enliven Therapeutics, Inc. (ELVN) is dated April 27, 2026. Enliven Therapeutics, Inc. reported in an 8-K filed December 11, 2025 that Richard Fair was appointed member of the board of directors, effective December 11, 2025. Enliven Therapeutics, Inc. reported in an 8-K filed December 11, 2025 that Richard Fair was appointed President and Chief Executive Officer, effective December 11, 2025. The proxy statement of Enliven Therapeutics, Inc. reports total compensation of $11,918,926 for Richard Fair in fiscal 2025, including a base salary of $38,077. Enliven Therapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Enliven Therapeutics, Inc. includes Rick Fair (CEO and Board Member), Sam Kintz, M.B.A. (CEO and Board Member), Samuel Kintz (CEO) and 7 others.
“On December 11, 2025, Enliven Therapeutics, Inc. (the "Company") announced the appointment of Richard Fair as the Company's President and Chief Executive Officer and as a member of the board of directors (the "Board") of the Company, effective as of December 11, 2025 (the "Effective Date").”
“On December 11, 2025, Enliven Therapeutics, Inc. (the "Company") announced the appointment of Richard Fair as the Company's President and Chief Executive Officer and as a member of the board of directors (the "Board") of the Company, effective as of December 11, 2025 (the "Effective Date").”
Affiliation history
-
Current
Start not stated–present
Last confirmed April 27, 2026
-
Current
Start not stated–present
Last confirmed April 27, 2026
Company network
Leadership on record at Enliven Therapeutics, Inc.
- Rick Fair CEO, Board Member
- Sam Kintz, M.B.A. CEO, Board Member
- Samuel Kintz CEO
- Richard Heyman, Ph.D. Chairman, Board Member
- Ben Hohl CFO
- Benjamin Hohl CFO
- Anish Patel COO
- Andrew Phillips, Ph.D. Board Member
- Continuing Directors Board Member
- Jake Bauer Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Enliven Therapeutics, Inc. (ELVN) | M.B.A. President and Chief Executive Officer | $38,077 | $11,918,926 |